Treatment of recurrent hepatitis C virus infection after liver transplantation

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 222-226

  Lavezzo, Bruna ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Combination therapy; HCV recurrence; Interferon; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENTIATION; FATIGUE; FEVER; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; LEUKOPENIA; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; THROMBOCYTOPENIA;

EID: 0033451931     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80406-1     Document Type: Conference Paper

References (22)

1. Wright HI, Gavaler JS, Vim Thiel DH. Preliminary experience with alpha-2b Interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992: 53: 121-124.
2. Wright TL, Combs C, Kim M, Ferell L, Bachetti P, Ascher N et al. Interferon alpha therapy for hepatitis C virus infection following liver transplantation. Hepatology 1994: 20: 773-779.
3. Gane EJ, Lo Su-Kong, Riordan SM, Portmann BC, Lau JYN, Naoumov NV et al. A randomized study comparing ribavirin and interferon alpha monotherapy for Hepatitis C recurrence after liver transplantation. Hepatology 1998: 27: 1403-1407.
4. Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C et al. An open trial of IFN alpha recombinant for hepatitis C after liver transplantation. Hepatology 1995: 22: 1084-1089.
5. Vargas V, Charco R, Castells L, Esteban R, Margarit C. Alphainterferon for acute hepatitis in liver transplant patient. Transplant Proc 1995: 27: 1222-1223.
6. Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients. N Engl J Med 1994: 330: 11601161.
7. Cattral MS, Krakden M, Wanless IR, Rezig M, Cameron R, Greig PD et al. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996: 61: 1483-1488.
8. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J et al. Pilot study of the combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997: 26: 500-504.
9. Gotz G, Schon MR, Haefker A, Neuhaus H, Berg T, Hopf U et al. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin. Transplant Proc 1998: 30:S 2104-2106.
10. Lavezzo B, Leone N, Smedile A, Ottobrelli A, Ghisetti V, Franchello A et al. Combination therapy of interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation. J Hepatol 1999: 30 (Suppl 1): 67.
11. Bellati G, Albert! AB, Belli LS, Vai C, Airoldi A, Rondinara GF et al. Therapy of chronic hepatitis C after liver transplantation: multicenter Italian experience. J Hepatol 1999: 30 (Suppl 1): 51.
12. Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali M et al. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. Transplant Proc 1997: 29: 519-521.
13. Reddy KR, Weppler D, Zervos XA, Nery OR, Webb MG, Khan MF et al. Recurrent HCV infection following OLTX: the role of early post OLTX interferon treatment (Abstract). Hepatology 1996, 24 (suppl): 295A.
14. Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau N et al. The efficacy of prophylactic interferon alpha-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998: 28: 831-838.
15. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K et al. Severe multiple rejection episodes are associated with early recurrence of hepatitis C after liver orthotopic liver transplantation. Hepatology 1995: 21: 30-34.
16. Berenguer M, Prieto M, Cordoba J, Rayun JM, Carrasco D, Olaso V et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998: 28: 756-763.
17. Martin P, Goldstein RM, Crippin J, Artinian L, Wu LL, Klintmalm GD et al. A prospective controlled trial of tacrolimus vs cyclosporine in orthotopic liver transplant recipients with hepatitis C virus: lack of effect on HCV-RNA. J Hepatol 1999: 30 (Suppl 1): 68.
18. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatement. Hepatology 1994: 19: 273-279.
19. Fukumoto T, Bergh T, Ku Y, Bechstein WO, Knoop M, Lemmens HP et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turn over of serum virions. Hepatology 1996: 24: 1351-1354.
20. Gane EJ, Naoumov NY Qian KP, Mondelli MU, Maertens G, Portman BC et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996: 110: 167-177.
21. Belli LS, De Carlis L, Rondinara G, Albert! AB, Bellati G, De Gasperi A et al. Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of prospective, randomized trial. Hepatology 1998: 27: 1524-1529.
22. Platz KP, Mueller AR, Berg T, Neuhaus R, Hopf U, Lobeck H et al. Searching for the optimal management of hepatitis C patients after liver transplantation. Transplant Int 1998: 11 (Suppl 1): S 209-211.